Charles W. Gorodetzky

Us Worldmeds, Llc

$20,848,803

Attributed

$23,389,670

Total exposure

Grants

Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $7.4M · FY2011–16

$10M$7.5M$5M$2.5M$0

'11

'12

'13

'14

'15

'16

Funding mix

By agency

NIH$23,389,670 · 2

By mechanism

U01$23,389,670 · 2

Top collaborators

James Alvan Longstreth6 shared

Most similar at Us Worldmeds, Llc

Same institution · by research overlap

James Alvan Longstreth$2,540,867
Kristen Leann Gullo$6,476,657

Others in their field

Top investigators on “Adrenergic Agonists”

Scott T Weiss · University Of California, San Diego$28,854,117
Elliot Israel · Brigham And Women'S Hospital$16,753,788
Brian K Kobilka · Stanford University$15,936,079
Stephen B Liggett · University Of South Florida$12,698,317
Sherry McKee · Yale University$12,420,664
Xinhua Li · Nano Terra, Inc.$11,941,250

Research focus

Adrenergic AgonistsDoseTherapy DevelopmentWithdrawalPharmaceutical PreparationsMethadoneMarketingSafetyOpiatesUrineOpioid WithdrawalFda ApprovedProduct LabelingProgramsAcuteBuprenorphineLofexidineOpioidMedicalEvaluationPhase 3 StudyBaseMeetingsApplications Grants